Clinical Trials Using Allogeneic iPSC-derived Anti-MICA/B CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT536
Review the clinical trials studying allogeneic ipsc-derived anti-mica/b car/cd16/il-15rf-expressing cd38-eliminated nk cells ft536 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota